- Current report filing (8-K)
06 Junio 2011 - 2:53PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 2,
2011
MABCURE INC.
(Exact name
of registrant as specified in its charter)
Nevada
(State or other jurisdiction of
incorporation)
333-141131
(Commission File Number)
20-4907813
(IRS Employer Identification
No.)
760 Parkside Avenue # 208
Brooklyn, NY 11226
(Address of principal executive offices and Zip Code)
(914) 595-6342
(Registrant's telephone
number, including area code)
N/A
(Former name or former address, if
changed since last report)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d -2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e -4(c))
Item 5.02
|
Departure of Directors or Principal
Officers; Election of Directors; Appointment of Principal
Officers
|
Resignation of Gad Berdugo
On June 2, 2011, Mr. Gad Berdugo
resigned from the Board of Directors of the Company for personal reasons. Mr.
Berdugo did not serve on any committees of the Board of Directors. The
resignation was not the result of any disagreement with the Company relating to
the Companys operations, policies, or practices.
SIGNATURES
Pursuant to the requirements of
the Securities Exchange Act of 1934, the Registrant has duly caused this report
to be signed on its behalf by the undersigned hereunto duly authorized.
|
MABCURE INC.
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/
Dr. Amnon Gonenne
|
|
|
Dr. Amnon Gonenne
|
|
|
President and Chief Executive Officer
|
Date: June 6, 2011
MabCure (CE) (USOTC:MBCI)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
MabCure (CE) (USOTC:MBCI)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024